
Dubai, UAE – September 2025 – DUBIMED proudly participated as Pearl Sponsor at the MEIDAM Congress 2025, the leading regional meeting in dermatology and aesthetic medicine. This year marked a historic milestone as DUBIMED officially became a GE Healthcare distributor, launching the revolutionary VScan™ and Venue Lines™ ultrasound solutions. These cutting-edge technologies are designed to help aesthetic healthcare professionals achieve safer, more precise results in regenerative medicine and longevity treatments.
The highlight of MEIDAM 2025 was the exclusive launch of GE Healthcare’s latest ultrasound technologies, introduced to the aesthetic market by DUBIMED:
This partnership reinforces DUBIMED’s mission to equip the GCC’s healthcare professionals with world-class solutions that elevate patient safety, diagnosis, and treatment planning.
In addition to the GE Healthcare launch, DUBIMED showcased a strong lineup of aesthetic medical devices that reflect innovation and leadership in the field:
Our soft product portfolio attracted significant attention, offering proven protocols in regenerative medicine and long-term skin health:
DUBIMED hosted and supported several scientific workshops, led by internationally renowned doctors and KOLs, covering regenerative medicine protocols, peptides, skin revitalization, and body contouring. Highlights included:
These sessions reinforced DUBIMED’s leadership in training and education, supporting healthcare professionals in adopting the latest technologies for skin rejuvenation and longevity treatments.
To create a unique experience at MEIDAM 2025, DUBIMED introduced interactive booth activations that combined science, creativity, and emotional engagement:
These activations highlighted DUBIMED’s human-centered approach, emphasizing the importance of connection in regenerative and aesthetic medicine.
By serving as Pearl Sponsor at MEIDAM Congress 2025, launching GE Healthcare’s VScan™ and Venue Lines™, and showcasing an extensive portfolio of aesthetic devices and regenerative products, DUBIMED reaffirmed its position as a leader in the GCC’s aesthetic and longevity treatment landscape.